Assure (IONM) Competitors

Assure (NASDAQ:IONM) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership, profitability and media sentiment.

Does the media refer more to IONM or BIOL?

In the previous week, Assure had 1 more articles in the media than BIOLASE. MarketBeat recorded 1 mentions for Assure and 0 mentions for BIOLASE. Assure's average media sentiment score of 0.76 beat BIOLASE's score of 0.00 indicating that Assure is being referred to more favorably in the media.

Company	Overall Sentiment
Assure	Positive
BIOLASE	Neutral

Do institutionals and insiders hold more shares of IONM or BIOL?

3.3% of Assure shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 3.8% of Assure shares are held by insiders. Comparatively, 0.3% of BIOLASE shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has preferable earnings & valuation, IONM or BIOL?

BIOLASE has higher revenue and earnings than Assure.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$149K	1.01	-$26.08M	N/A	N/A
BIOLASE	$48.83M	0.00	-$20.63M	-$14.94	N/A

Which has more risk and volatility, IONM or BIOL?

Assure has a beta of 185.75, indicating that its share price is 18,475% more volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500.

Do analysts prefer IONM or BIOL?

BIOLASE has a consensus target price of $1.20, suggesting a potential upside of 0.00%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Assure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIOLASE	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is IONM or BIOL more profitable?

BIOLASE has a net margin of -41.65% compared to Assure's net margin of -25,178.32%. Assure's return on equity of 0.00% beat BIOLASE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
BIOLASE	-41.65%	-1,782.73%	-55.31%

Summary

BIOLASE beats Assure on 8 of the 13 factors compared between the two stocks.